Introduction: There is concern that surgical quality initially declines during the learning phase of robotic surgery. At our institution, we used a multi-surgeon programmatic approach to the introduction of robotic surgery. The purpose of this study was to evaluate outcomes of patients treated during the first year of our program. Methods: This is a historical cohort of all radical prostatectomy patients during a one-year period. Baseline, perioperative, and long-term followup data were prospectively and retrospectively collected. Treatment failure was a composite of any postoperative radiation, androgen-deprivation, or prostate-specific antigen (PSA) ≥0.2. Results: During the study period, 225 radical prostatectomy procedures were performed (104 robotic and 121 open). Baseline characteristics were similar between groups (p>0.05). All patients were continent and 74% were potent prior to surgery. Mean estimated blood loss (280 cc vs. 760 cc; p<0.001) and blood transfusion (0% vs. 8.3%; p=0.002) was lower in the robotic cohort. Non-transfusion complications were similar between groups (13% vs. 12%; p=0.7). Mean hospital stay was shorter in the robotic cohort (1.4 vs. 2.5 days). There was no difference in overall positive margin rate (38% vs. 43%; p=0.4) or treatment failure at a median followup of 3.5 years (p=0.4). Robotically treated patients were more often continent (89% vs. 77%; p=0.02) and potent (48% vs. 32%; p=0.02). Conclusions: Using an inclusive multi-surgeon approach, robotic prostatectomy was introduced safely at a Canadian academic institution.
Introduction
Robotic assisted laparoscopic radical prostatectomy (RALRP) has gained popularity for the surgical treatment of prostate cancer. Advantages of the robotic approach include better surgeon ergonomics, improved visualization, and easier instrumentation compared to pure laparoscopy. RALRP may result in less blood loss, fewer blood transfusions, less time in hospital, and quicker recovery with equivalent cancer outcomes and long-term quality of life compared to an open surgical approach. [1] [2] [3] [4] [5] [6] Disadvantages of robotic prostatectomy is the higher cost per case, and potentially the learning curve associated with adoption of a new surgical procedure.
Hospitals may offer only open or robotic surgery while others offer both based on surgeon preference and resource availability. Over the last decade, the use of RALRP has increased in many jurisdictions. In the U.S., a robotic approach increased from approximately 1% of patients in 2001 to 70% by 2012. 7, 8 In contrast to the rapid uptake of robotic surgery in the U.S., uptake in Canada has been much slower. The proportion of cases being performed robotically in Canada was 19% in 2012-2013. 9 Presumably, the cost of robotic surgery will decrease over time and more centres in Canada will develop a robotic surgery program and offer this surgical option to prostate cancer patients.
There is no standard method to optimally implement a robotic surgery program. Some centres may limit the number of surgeons who perform robotic surgery, while others may adopt a more inclusive, multi-surgeon approach. At our institution, the robotic surgery program was introduced using a multi-surgeon approach. We believed that inclusion of multiple surgeons would allow for a more rapid program expansion and we hoped there would not be a negative impact on patient outcomes. In this study, we report the outcomes of patients receiving robotic surgery during the first year of implementation of our multi-surgeon robotic surgery program compared to patients over the same time period treated with open prostatectomy. 
Methods

Clinical setting
Institutional ethics review board approval was obtained. This was a historical cohort of prospectively collected data for all patients who underwent radical prostatectomy (open or robotic) from October 31, 2011 to October 31, 2012 at our institution. The surgeons performing RALRP included one with robotic surgery fellowship training (RB), two experienced in laparoscopic prostatectomy (BB, JW), and one experienced in open prostatectomy but with no laparoscopic experience (CM). All surgeons performing open prostatectomy had oncology fellowship training (RB, IC, CM) or were highly experienced with this procedure (FD, RG, JM, JO, and JW). No criteria were used to select patients for RALRP or open prostatectomy. The choice of which procedure was performed was based on who operated on the patient and resource availability. Since the wait times were generally longer for RALRP, higher-risk patients may have more frequently received open prostatectomy to reduce their wait time to surgery.
All surgeons performing RALRP attended a training session at an Intuitive Surgical training facility prior to the first case. The robotic-trained urologist mentored the other surgeons until both the mentor and the mentee were confident that routine mentoring was no longer required. A common anesthesia pathway was used, but no specific anesthesiology training or anesthesiologist was required. The nursing team leader (RW) received training at an Intuitive Surgical training facility and he subsequently trained the remainder of the nursing team. All patients followed a common perioperative care pathway. All surgeons followed similar surgical steps using standardized instruments and sutures. All RALRPs were performed using the da Vinci surgical robot system (Intuitive Surgical, Sunnyvale, CA, U.S.) and a transperitoneal approach.
Baseline characteristics
Preoperative characteristics, including patient age, body mass index (BMI), preoperative prostate-specific antigen (PSA), prostate volume, patient American Society of Anesthesiologists (ASA) class, PSA density, prostate volume, preoperative erectile function, digital rectal exam (DRE) result, biopsy Gleason score, number of positive cores, and tumour grade, were abstracted from the medical record.
Surgery characteristics
Intraoperative parameters, such as the estimated blood loss (EBL), number of nodes removed, nerve-sparing technique, operative time, intraoperative complications, and positive margin status, were prospectively recorded in a database.
Postoperative outcomes
Postoperative complications until discharge were collected from the medical record. Postoperative complications were classified by their severity based on the Clavien-Dindo scale. 10 The Clavien-Dindo classification system is used to grade the severity of adverse events that occur as a result of surgical procedures. More details on this classification system can be found online (http://www.surgicalcomplication.info/index-2. html). As part of the clinical pathway, all robotic patients had pelvic drain fluid analyzed for creatinine irrespective of symptoms and output volumes. Open prostatectomy patients did not have routine drain creatinine analyzed unless the drain output was high. Patients were typically seen at least three, six, nine, 12, 18, 24, and 36 months postoperatively and oncological and functional outcomes were recorded at each visit. Biochemical failure was defined as PSA ≥0.2. If postoperative radiation or androgen deprivation was initiated, the date of therapy commencement was recorded. A composite outcome of primary treatment failure was defined as one or more of: a postoperative PSA ≥0.2, postoperative radiation, or postoperative androgen deprivation.
Data analysis
Baseline characteristics and outcomes of patients receiving open and robotic surgery were summarized and compared using descriptive statistics. Treatment failure-free survival was calculated from surgery to any of the composite endpoint events. Patients were censored at last followup or death. The Kaplan-Meier method was used to estimate survival, and a log-rank test was used to test for differences in the treatment failure-free survival between groups. Univariable and multivariable cox proportional hazard regression was used to estimate hazard ratios of cancer recurrence associated with the surgical approach, preoperative PSA levels, pathological Gleason score, and pathological tumour stage. A p value <0.05 was considered significant. No adjustment was made for multiple testing and all analyses were performed using SAS (SAS Institute Inc., Cary, NC, U.S.). To encourage participation of all surgeons, it was decided a priori that no analysis would be performed comparing results between individual surgeons.
Results
Patient characteristics
A total of 225 patients underwent radical prostatectomy during the study period; 104 were performed robotically and 121 were performed using an open approach. 
Surgical parameters
Surgical outcomes are presented in Table 2 . The operating room time was similar between groups (p=0.10). The blood loss was 278.7 ±220.1 ml in the robotic group compared to 756.8 ±451. 8 
Oncological outcomes
Oncological outcomes are presented in Table 3 . The prostatectomy pathology specimen showed Gleason score 3+3, 3+4, 4+3 and ≥8 to be comparable between groups (p=0.81).
The risk of a positive surgical margin was similar between groups (p=0.4). No significant difference was observed when patients were stratified by pT2 or pT3 tumours. The risk of cancer recurrence (p=0.48), the number of patients having a 36-month PSA ≥0.2 (p=0.97), and the number of patients requiring postoperative hormonal (p=0.35) or radiation (p=0.62) therapy was comparable between groups. The overall three-year treatment failure-free survival using the composite endpoint was 62.0%, with no statistical difference between the two cohorts (p=0.53) (Fig. 1) . Preoperative PSA, prostatectomy tumour stage, and prostatectomy Gleason score were significantly associated with an increased risk of cancer recurrence (Table 4 ). The surgical approach was not predictive of cancer recurrence.
Functional outcomes
Preoperative erectile function was slightly higher in the robotic cohort (77% vs. 72% able to achieve penetration). At last followup, more patients had erectile function adequate for penetration in the robotic group (48% vs. 32%; p=0.02) ( Table 5) . When stratified by nerve-sparing technique, of the patients who underwent a bilateral nerve-sparing procedure, a higher proportion of patients in the robotic group had adequate postoperative erectile function (p=0.04) ( Table  6 ). At last followup, almost 90% of patients in the robotic group were fully continent compared to 77.4% of patients in the open group (p=0.02). When stratified by nerve-sparing technique, similar associations were observed (Table 7) .
Discussion
At our institution, we adopted a programmatic approach and assembled a core team of surgeons, nurses, administrators, and anesthetists who were dedicated to the initiation of the program and who consistently attended planning meetings, training sessions, and actual walk-through surgical rehearsals prior to the first case being done. All surgeons completed a standardized set of robotic surgical simulation programs on the da Vinci simulator and we included multiple surgeons with a consistent surgical team with the aim of mitigating some of the potential concerns with the learning phase of new technology.
11
The present study reports three-year followup data on 225 patients who had prostatectomy performed during the first year of our robotic surgery program, 104 of which were performed robotically. We had permissive inclusion criteria, as is reflected in the similar baseline characteristics. Reassuringly, we did not observe worse cancer outcomes in RALRP patients compared to those treated by experienced surgeons using an open approach. Furthermore, the benefits of the laparoscopic approach were consistent with other series. RALRP patients had lower blood loss, 3, 4, 6 fewer transfusions, 6, 12, 13 and shorter length of hospital stay. 11, 12 In the current study, there were no intraoperative complications or conversions to an open approach. The overall postoperative complication rate in our study was 12.4%, and the rate was comparable between the two groups. Some studies have shown a decrease in complications associated with RALRP, 14, 15 others have simply shown equivalence to open cases; 16, 17 however, some evidence suggests the complications experienced with RALRP are less severe, 12 consistent with our findings. Five percent of patients in the open group experienced a bladder neck contracture, while none of the patients in the robotic group experienced such a complication. The higher risk of anastomotic leak in the robotic cohort is of questionable clinical significance, and may be a reflection of detection bias since all RALRP patients had drain fluid creatinine analyzed.
While we believe our inclusive-surgeon approach facilitated good patient outcomes, we do not know if outcomes would have been better using a more restrictive-surgeon approach. To our knowledge, and not surprisingly, there are no randomized trials or observational studies comparing robotic implementation strategies. At least one published study using a single-surgeon approach has shown a potential decrease in patient outcomes during the learning phase, but it is unclear if this would have been improved or worsened using a multisurgeon approach. 18 Similarly, while there are small series of multi-surgeon approaches with favourable safety outcomes, it is unclear if this would have been altered with a singlesurgeon series. 19 Certainly, having a dedicated anesthesia and nursing team are important to facilitate the safe and efficient implementation of a robotic surgery program, 20 and the team benefits by the larger number of cases that are possible by including multiple surgeons. Lastly, a surgeon mentor trained in robotic surgery is critical to program success. 21, 22 This is an observational study and associations we observed may be due to confounding or bias. The selection between treatments was based primarily on the preference of the surgeon evaluating the patient or the resources available. Another limitation was the inconsistent use of validated patient function instruments. It is also worth noting that this is a single-centre study and generalizability of our findings has not yet been established.
Conclusion
Using an inclusive multi-surgeon approach with a robotically trained mentor, RALRP was introduced safely at a Canadian academic institution. Short-term and long-term long-term robotic surgery outcomes patient outcomes during the first year of our robotic surgery program were equivalent or better than patients treated with open surgery during the same time period. By including multiple surgeons, a high procedure volume was achieved and this allowed for a rapid attainment of experience for the anesthesia and dedicated nursing teams. We believe our approach should be considered by other institutions initiating a robotic surgery program.
